This page presents the OECD statistical work on human resources in science and technology, more specifically the OECD/UNESCO Institute for Statistics/Eurostat project on careers of doctorate holders.
The aim of this consultation, held on 20-21 June 2013 in Oxford (UK), was to stimulate discussion at the highest possible level of expert engagement in setting out an agenda for OECD action to accelerate innovation for Alzheimer’s disease and dementia.
The economic and social impact of chronic brain disorders such as Alzheimer’s and other neurodegenerative diseases will become the #1 public health problem worldwide by 2050, directly affecting 100 million people. Ongoing demographic trends, namely ageing populations, are leading to the unprecedented expansion of consumer demand for healthcare services, which will confront a serious crisis in a climate of shrinking resources.
Countries/regions have begun to develop and refine regulatory approaches for foods and medical products and invest in regulatory science and other research efforts to support the responsible development of nanotechnology in these areas. This paper inventories and analyses regulatory approaches, legislative regimes and government-sponsored research programmes and infrastructure in foods and medical products that involve nanotechnology.
The Southeast Asian (SEA) region is one of the most dynamic in the world. It is in a period of transition as its national economies become strongly integrated into global knowledge networks. Science and technology (S&T) offer opportunities for countries to ‘move up the value chain’. A better understanding of existing capabilities helps enhance mutually beneficial S&T and innovation co-operation between SEA and OECD
The April 2013 meeting of the OECD Global Forum saw the official launch of Scientific Collections International (SciColl), a new international network devoted to promoting interdisciplinary research that relies on scientific collections.
OECD Global Science Forum report on data and research infrastructure for the social sciences.
This framework introduces a risk-based oversight and management methodology for clinical trials. It combines a stratified approach that is based on the marketing authorisation status of the medical product and can be applied in a common manner across countries’ regulatory frameworks, with a trial-specific approach that considers other issues such as the type of populations concerned by the trial, or the informed consent of the patients.
This OECD Review of Innovation Policy for Sweden offers a comprehensive assessment of Sweden's innovation system, focusing on the role of government. It provides concrete recommendations on how to improve policies that affect innovation performance, including R&D policies, and identifies good practices from which other countries can learn.
This paper presents a new edition of the project's technical guidelines including methodological guidelines, a core model questionnaire and instruction manual, and the output tables used for reporting data at the international level and related definitions.